Myocarditis and cardiomyopathy;Miocarditis y miocardiopatías

Revista Espanola de Cardiologia Suplementos

Volumn 6, Issue E, 2006, Pages

  Laraudogoitia, Eva ^a,c   Díez, Ignacio ^b  

^a HOSPITAL DE GALDAKAO   (Spain)

^b HOSPITAL TXAGORRITXU   (Spain)

^c NONE   (Spain)

Author keywords

Cardiomyopathy; Cardiovascular magnetic resonance; Contrast enhancement; Myocarditis

Indexed keywords

AMYLOIDOSIS; ARTICLE; CARDIOMYOPATHY; CHAGAS DISEASE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; ENDOMYOMETRITIS; FABRY DISEASE; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HEMOCHROMATOSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTERMETHOD COMPARISON; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOCARDIOGRAPHY; SARCOIDOSIS; SYMPTOM;

EID: 35948986750     PISSN: 11313587     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Kishimoto C, HirakokaY. Clinical and experimental studies in myocarditis. Curr Opin Cardiol. 1994;9:349-56.
2. Theleman KF, Nuipper JJ, Roberts WC. Acute myocarditis sudden death without heart failure. Am J Cardiol. 2001;88:1078-83.
3. Brady WJ, Ferguson JD, Ullman EA, Perron AD. Myocarditis: emergency departament recognition and management. Emerg Med Clin N Am. 2004;22:865-85.
4. Angelini A, Calzolari V, Calabrese F, Boffa GM, Magdalena F, Chioin R, et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the diferencial diagnosis. Heart. 2000;84:245-50.
5. Sarda L, Colin P, Boccara F, Daou D, Lebtahi R, Faraggi M, et al. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol. 2001;37:786-92.
6. Veluvolu P, Balian AA, Goldsmith R, Gallant TE, Barthel L, Vidaillet HJ, et al. Lyme carditis evaluation by Ga-67 and MRI. Clin Nucl Med. 1992;17:823-7.
7. Kuhl U, Lauer B, Souvatzoglu M, Vosberg H, Schultheiss HP. Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with suspected myocarditis: evidence of myocardial cell damage and inflamation in the absence of histologic signs of myocarditis. J Am Coll Cardiol. 1998;32:1371-6.
8. Yasuda T, Palacios IF, Dec GW, Fallon JT, Gold HK, Leinbach RC, et al. Indium 111-monoclonal antimyosin-antibody imaging in the diagnosis of acute myocarditis. Circulation. 1987;76:306-11.
9. Bergler-Klein J, Sochor H, Stanek G, Globits S, Ullrich R, Glogar D. Indium 111-monoclonal antimyosin antibody and magnetic resonance imaging in the diagnosis of acute Lyme carditis. Arch Intern Med. 1993;153:2696-700.
10. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3-14.
11. Friedrich MG, Strohm O, Shultz-Menger J, Marciniak H, Luft FC, Dictz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in course of viral myocarditis. Circulation. 1998:97:1802-9.
12. Kubo N, Morimoto S, Hiramitsu S, Uemura A, Kimura K, Shimizu K, et al. Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy. Heart Vessels. 1997;12:167-70.
13. Gagliardi MG, Bevilacqua M, Di Renzi P, Picardo S, Passariello R, Marceletti C. Usefulness of magnetic resonance imaging for the diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol. 1991;68:1089-91.
14. Di Cesare E. MRI of the cardiomyopathies. Eur J Radiol 2001;38:179-84.
15. Roditi GH, Hartnell GG, Cohen MC. MRI changes in myocarditis-Evaluation with spin echo cine MR angiography and contrast enhanced spin echo imaging. Clinical Radiology. 2000;55:752-8.
16. Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, et al. Diagnostic performance of Cardiovascular Magnetic resonance in patients with suspected acute myocarditis. Comparison of Different approaches. J Am Coll Cardiol. 2005;45:1815-22.
17. Mahrholdt H, Goedeke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology. Circulation. 2004;109:1250-8.
18. Laissy JP, Messin B, Varenne O, Iung B, Karila-Cohen D, Schouman-Claeys E, et al. MRI of acute myocarditis: A comprehensive approach based on various imaging sequences. Chest. 2002;122:1638-48.
19. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis. Mayo Clin Proc. 1989;64:1235-45.
20. Shirani J, Freant LJ, Roberts WC. Gross and semiquantitative histologic findings in mononuclear cell myocarditis causing sudden death, and implications for endomyocardial biopsy. Am J Cardiol. 1993;72:952-7.
21. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies Eur Heart J. 2005;26:1461-74.
22. Imai H, Kumai T, Sekiya M, Kobayashi S, Sakakibara M, Imazeki Y, et al. Left ventricular trabeculae evaluated with MRI in dilated cardiomyopathy and old myocardial infarction. J Cardiol. 1992;22:83-90.
23. Wu E, Judd RM, Vargas J. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357:21-8.
24. Bello D, Shah DJ, Farah GM. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108:1945-53.
25. Schuster EH, Bulkley BH. Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients. Am Heart J. 1980;100:506-12.
26. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopath: analysis of 152 necropsy patients. Am J Cardiol. 1987;60:1340-55.
27. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54-9.
28. Bogaert J, Taylor AM, Van Kerckhove F, Dymarkowski S. Use of inversion-recovery contrast-enhanced MRI technique for cardiac imaging: spectrum of diseases. Am J Roentgenol. 2004;182:609-15.
29. Bergey PD, Axel L. Focal hypertrophic cardiomyopathy simulating a mass: MR tagging for correct diagnosis. Am J Roentgenol. 2000;174:242-4.
30. Young AA, Kramer CM, Ferrari VA, Axel L, Reichek N. Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy. Circulation. 1994;90:854-67.
31. Rickers C, Wilke NM, Jerosch-Herold M, Casey S, Panse P, Panse N, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112:855-61.
32. Moon JCC, McKenna WJ, McCrohon JA. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41:1561-7.
33. Varnava AM, Elliot PM, Sharma S, McKenna WJ, Davies MJ. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart. 2000;84:476-82.
34. Van Dockum WG, Ten Cate FJ, Ten Berg JM, Beek AM, Twisk JW, Vos J, et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol. 2004;43:27-34.
35. Maceira AM, Joshi J, Prasad SK. CMR in Amyloidosis. Circulation. 2005;111:186-93.
36. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171-9.
37. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, et al. A single breath-hold multi-echo T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging. 2003;18:33-9.
38. Siegelman ES, Mitchell DG, Semelka RC. Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology. 1996;199:13-22.
39. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'-Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1996;93:841-2.
40. Blake LM, Scheinman MM, Higgins CB. MR features of arrhythmogenic right ventricular dysplasia. AJR Am J Roentgenol. 1994;162:809-12.
41. Midiri M, Finazzo M, Brancato M, Hoffmann E, Indovina G, Maria MD, et al. Arrhythmogenic right ventricular dysplasia: MR features. Eur Radiol. 1997;7:307-12.
42. Bluemke DA, Krupinski EA, Ovitt T, Gear K, Unger E, Axel L, et al. MR imaging on arrhythmogenic right ventricular cardiomyopathy: morphological findings and interobserver reliability. Cardiology. 2003;99:153-62.
43. Aviram G, Fishman JE, Young ML, Redha E, Biliciler-Denktas G, Rodriguez MM. MR evaluation of arrhythmogenic right ventricular cardiomyopathy in pediatric patients. Am J Roetgnenol. 2003;180:1135-41.
44. Tandri H, Martinez C, Saranathan M. Non-invasive detection of myocardial fibrosis in arrythmogenic right ventricular dysplasia by delayed enhancement magnetic resonance imaging correlation with histopathology [abstract]. J Cardiovasc Magn Reson. 2004;6:44-5.
45. Rochitte CE, Olivera PF, Joalbo M. Chagas disease is characterized by specific pattern and location of myocardial delayed enhanced MRI [abstract]. J Cardiovasc Magn Reson. 2003;5:115.
46. Moon JC, Sachdev B, Elkington AG. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J. 2003;24:2151-5.
47. Vignaux O, Dhote R, Duboc D. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr. 2002;26:762-7.
48. Patel MR, Cawely PJ, Heitner JF. Improved diagnostic sensitivity of contrast enhanced cardiac MRI for cardiac sarcoidosis [abstract]. Circulation. 2004;108 Suppl:645.
49. Vignaux O, Dhote R, Blanche P. Myocardial MRI in sarcoidosis: 3-years follow-up and evaluation of the effects of steroid therapy [abstract]. J Cardiovasc Magn Reson. 2004;6:44.
50. Borreguero LJJ, Corti R, Soria RF. Diagnosis of noncompactation of the myocardium by magnetic resonance imaging. Circulation. 2004;105:e177-8.
51. Penell D, Sechtem U, Higgins C, Manning W, Pohost G, Rademakers F, et al. Clinical indications for cardiovascular magnetic resonance: Consensus panel report. Eur Heart J. 2004;25:1940-65.